馬の人工授精市場- 世界の産業規模、シェア、動向、機会、予測、ソリューション別、馬の種類別、流通チャネル別、地域別、競合市場別、2020-2030F

世界の馬の人工授精市場は、2024年に6億5,806万米ドルと評価され、2030年には9億2,324万米ドルに達し、CAGR5.78％で成長すると予測されています。

この市場は、生殖技術の進歩と遺伝的に優れた馬品種に対する需要の高まりによって、大幅な拡大を経験しています。馬産業界では人工授精（AI）の採用が増加しており、繁殖業者は遺伝的多様性を高め、疾病伝播のリスクを軽減することができるようになりました。レース、障害飛越、馬場馬術といった馬術競技の人気が高まっていることも、高性能馬の需要をさらに高めており、生殖補助技術の利用を促しています。業界のリーダーたちは、受胎率を高めるために精液保存技術の向上と人工授精法の革新に力を注いでおり、その結果、繁殖牧場や動物病院全体でAIが広く採用されるようになっています。

主な市場促進要因

馬の遺伝的改良

主要市場の課題

規制への対応：複雑な情勢

主な市場動向：

ゲノム検査による高精度な遺伝子選択

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の馬の人工授精市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • ソリューション別（機器・消耗品、精液（通常精液、性別判別精液）、サービス）
  • 馬の種類別（スポーツ・競馬、レクリエーション、その他）
  • 流通チャネル別（民間、公共）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • ソリューション別
  • 馬の種類別
  • 流通チャネル別
  • 地域別

第6章 北米の馬の人工授精市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の馬の人工授精市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の馬の人工授精市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の馬の人工授精市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの馬の人工授精市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• IMV Technologies SADIR
• Stallion A I Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc S.r.o.
• CVS UK Ltd
• HOFFMAN A.I. BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Equine Artificial Insemination Market was valued at USD 658.06 million in 2024 and is projected to reach USD 923.24 million by 2030, growing at a compound annual growth rate (CAGR) of 5.78%. This market is experiencing substantial expansion, driven by advancements in reproductive technologies and a growing demand for genetically superior horse breeds. The increasing adoption of artificial insemination (AI) within the equine industry has enabled breeders to enhance genetic diversity and mitigate the risk of disease transmission. The rising popularity of equestrian sports, such as racing, show jumping, and dressage, is further fueling the demand for high-performance horses, thus encouraging the use of assisted reproductive technologies. Industry leaders are focusing on improving semen preservation techniques and innovating insemination methods to enhance fertility rates, resulting in broader adoption of AI across breeding farms and veterinary clinics.

Key Market Drivers:

Genetic Improvement in Equine Traits

The equine breeding industry is undergoing a significant shift, driven by the pursuit of superior genetic traits in horses. This quest for genetic excellence has accelerated the growth of the Global Equine Artificial Insemination (AI) Market as breeders increasingly rely on advanced reproductive technologies to improve and refine the genetic composition of their horses. Artificial insemination offers several advantages over traditional mating methods, including access to genetic material from top sires worldwide, which breaks geographical barriers and diversifies the gene pool. This technology allows breeders to selectively pair stallions with desirable traits-such as speed, endurance, agility, and temperament-to produce offspring suited for various disciplines like racing, show jumping, dressage, and workhorse functions.

Additionally, AI helps preserve genetic diversity within equine populations, minimizing the risks associated with inbreeding by introducing fresh genetic material. The technology also accelerates genetic progress by enabling the production of multiple offspring from a single stallion in one breeding season, thus enhancing the breed's overall quality and performance. The demand for high-quality, genetically superior horses is rising, fueled by competitive sports, leisure riding, and other equine-related activities. As breeders aim to meet these market demands, artificial insemination has become a vital tool in achieving their goals. For instance, the equine industry in the United Kingdom plays a significant role in the economy, with substantial spending on breeding, training, and recreational activities. The Department for Environment, Food & Rural Affairs (DEFRA) regulates equine semen collection and storage, ensuring compliance with rigorous standards to safeguard the health and quality of the equine population.

Key Market Challenges:

Regulatory Compliance: A Complex Landscape

A primary challenge in the equine artificial insemination market is navigating the complex and varied regulatory landscape across different countries and regions. Each jurisdiction has its own set of rules governing equine breeding practices, including the use of artificial insemination. Ensuring compliance with these regulations can be a challenging task, particularly for breeders engaged in international trade. Understanding and adhering to these regulatory requirements is crucial to ensuring the legality and acceptance of artificially inseminated horses in various markets.

Key Market Trends:

Precision Genetic Selection through Genomic Testing

The trend toward precision breeding is gaining traction within the equine industry. Genomic testing, which analyzes an individual horse's DNA to assess its genetic potential, is becoming more accessible and cost-effective. This technology allows breeders to make informed decisions about stallion and mare pairings, optimizing the likelihood of producing offspring with desirable traits. As genomic testing becomes more widely adopted, it is expected to lead to even more selective breeding practices, fostering the creation of superior equine bloodlines.

Key Market Players

• IMV Technologies SADIR
• Stallion A I Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc S.r.o.
• CVS UK Ltd
• HOFFMAN A.I. BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

Report Scope:

In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Artificial Insemination Market, By Solution:

• Equipment & Consumables
• Semen
  • Normal Semen
  • Sexed Semen
• Services

Equine Artificial Insemination Market, By Equine Type:

• Sports/Racing
• Recreation
• Others

Equine Artificial Insemination Market, By Distribution Channel:

• Private
• Public

Equine Artificial Insemination Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.

Available Customizations:

Global Equine Artificial Insemination market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Artificial Insemination Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 5.2.3. By Distribution Channel (Private, Public)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Solution
  • 5.3.2. By Equine Type
  • 5.3.3. By Distribution Channel
  • 5.3.4. By Region

6. North America Equine Artificial Insemination Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 6.2.3. By Distribution Channel (Private, Public)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Artificial Insemination Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Solution
      • 6.3.1.2.2. By Equine Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Equine Artificial Insemination Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Solution
      • 6.3.2.2.2. By Equine Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Equine Artificial Insemination Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Solution
      • 6.3.3.2.2. By Equine Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Equine Artificial Insemination Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 7.2.3. By Distribution Channel (Private, Public)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Artificial Insemination Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Solution
      • 7.3.1.2.2. By Equine Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Solution
      • 7.3.2.2.2. By Equine Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. France Equine Artificial Insemination Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Solution
      • 7.3.3.2.2. By Equine Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Equine Artificial Insemination Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Solution
      • 7.3.4.2.2. By Equine Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Equine Artificial Insemination Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Solution
      • 7.3.5.2.2. By Equine Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Equine Artificial Insemination Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 8.2.3. By Distribution Channel (Private, Public)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Equine Artificial Insemination Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Solution
      • 8.3.1.2.2. By Equine Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Japan Equine Artificial Insemination Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Solution
      • 8.3.2.2.2. By Equine Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. India Equine Artificial Insemination Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Solution
      • 8.3.3.2.2. By Equine Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. Australia Equine Artificial Insemination Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Solution
      • 8.3.4.2.2. By Equine Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. South Korea Equine Artificial Insemination Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Solution
      • 8.3.5.2.2. By Equine Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Equine Artificial Insemination Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 9.2.3. By Distribution Channel (Private, Public)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Artificial Insemination Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Solution
      • 9.3.1.2.2. By Equine Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Equine Artificial Insemination Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Solution
      • 9.3.2.2.2. By Equine Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Equine Artificial Insemination Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Solution
      • 9.3.3.2.2. By Equine Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Equine Artificial Insemination Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 10.2.3. By Distribution Channel (Private, Public)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Artificial Insemination Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Solution
      • 10.3.1.2.2. By Equine Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Solution
      • 10.3.2.2.2. By Equine Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Equine Artificial Insemination Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Solution
      • 10.3.3.2.2. By Equine Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. IMV Technologies SADIR
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Stallion A I Services Ltd
• 14.3. Zoetis Inc
• 14.4. Neogen Corp
• 14.5. Zerlotti Genetics Ltd
• 14.6. Erc S.r.o.
• 14.7. CVS UK Ltd
• 14.8. HOFFMAN A.I. BREEDERS INC.
• 14.9. Continental Genetics, LLC
• 14.10. Minitub GmbH

15. Strategic Recommendations

16. About Us & Disclaimer